Treatment of spasticity: An update;Tratamento da espasticidade: Uma atualizacao

Arquivos de Neuro-Psiquiatria

Volumn 56, Issue 4, 1998, Pages 852-858

  Teive, Hélio A G ^a,c   Zonta, Marise ^b   Kumagai, Yumi ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b HOSPITAL DE CLÍNICAS   (Paraguay)

^c HC/UFPR ^*  (Brazil)

Author keywords

Botulinum toxin; Physical therapy; Spasticity

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BACLOFEN; BENZODIAZEPINE; BOTULINUM TOXIN; BOTULINUM TOXIN A; CHLORPROMAZINE; DIAZEPAM; GAMMA INTERFERON; MORPHINE; TIZANIDINE; ANTIPARKINSON AGENT;

ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; ELECTROMYOGRAM; HUMAN; MUSCLE TONE; PATHOPHYSIOLOGY; SPASTICITY; PHYSIOTHERAPY; REVIEW;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; HUMANS; MUSCLE SPASTICITY; PHYSICAL THERAPY MODALITIES;

EID: 0031795820     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1998000500025     Document Type: Article

References (30)

1. Brin MF. Treatment of spasticity using local injections of botulinum toxin, Skills Workshop Series Seattle American Academy of Neurology, 1995
2. O'Brien CF, Gormley ME, Winkler PA, Yablon AS. Fisiologia y tratamiento de la espasticidad. Deerfield. Discovery International, 1996
3. Young RR. Physiologic and pharmacologic approaches on spasticity In Scheimberg L, Shahani BT (eds). Neurologic rehabilitation. Philadelphia: Neurologic Clinics, W B Saunders 1987;5:529-539.
4. Mayer NH. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle & Nerve 1997;6(Suppl) S1-S13
5. Brodal A Anatomia neurológica com correlações clínicas 3.Ed. São Paulo Roca, 1984
6. Maeyr NH, Esquenazi A, Childers MK Common patterns of clinical motor dysfunction Muscle & Nerve 1997; 6(Suppl) S21-S35
7. Jozefczyk PB. Approach to the management of focal spasticity. Boston: American Academy of Neurology 1997.
8. Gelber DA. Approach to the management of generalized spasticity. Boston: American Academy of Neurology 1997.
9. Davidoff RA. Antispasticity drugs: mechanism of action. Ann Neurol 1985;17.107-116
10. Report of the Therapeutics and Technology Assessement Subcommittee, American Academy of Neurology. The clinical usefulness of botulinum toxin-A in treating neurologic disorders Neurology 1990,40 1332-1336.
11. Report of the Therapeutics and Technology Assessement Subcommittee American Academy of Neurology. Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Neurology 1994;44:2401-2403.
12. Gracies JM, Elovic, E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity Part I Local treatments. Muscle & Nerve 1997;6(Suppl) S61-S91
13. Gracies JM, Elovic, E. McGuire J, Simpson D. Traditional pharmacological treatments for spasticity: Part II General and regional treatments Muscle & Nerve 1997,6(Suppl):S92-S120.
14. AACD, ABPC, Allergan Workshop: Toxina botulínica. São Paulo, 1997.
15. Chambers, HG. The surgical tretament of spasticity. Muscle & Nerve 1997;6(Suppl):S121-S128
16. Albany K. The role of physical & occupational therapy in patients undergoing botulinum toxin management of spasticity New York: Botulinum Toxin Injection Workshop, 1996
17. Bobath B. Atividade postural reflexa anormal causada por lesões cerebrais. 2.Ed. São Paulo: Manole, 1978.
18. Bobath B. Hemiplejia del adulto valoracion e tratamiento. Buenos Aires Panamericana, 1973.
19. Johnstone M. Home care for the stroke patient living in a pattern. 3.Ed. New York: Churchill Livingstone, 1996.
20. Davies, PM Recomeçando outra vez reabilitação precoce após lesão cerebral traumática ou outra lesão cerebral severa São Paulo: Manole, 1997.
21. Cash JE. Neurologia para fisioterapeutas Buenos Aires: Panamericana, 1986.
22. Hesse S, Friedrich H, Domasch C, Mauritz KH. Botulinum toxin therapy for upper limb flexor spasticity: preliminary results J Rehab Sci 1992,5:98-101.
23. Brin MF. Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin. Arch Neurobiol 1991,54.7-23.
24. Pullman SL, Greene P, Fahn S, Pederson SF. Approach to the treatment of limb disorders with botulinum toxin. Arch Neurol 1996;53:617-624
25. Grazko MA, Polo KB, Jabbari B Botulinum toxin A for spasticity, muscle spams, and rigidity. Neurology 1995,45:712-717.
26. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto AS, Calne DB Treatment of spasticity with botulinum toxin, a double-blind study. Ann Neurol 1990,28.512-515.
27. Chutorian AM, Root L Management of spasticity in children with botulinum-A toxin. Internat Pediatr 1994;9:35-43.
28. Simpson DM Treatment of spasticity with botulinum toxin. In: Clinical usefulness of botulinum toxin tor the treatment of dystonia, spasticity, and other muscle cramps. Workshop 350, Seattle. American Academy of Neurology Annual Meeting, USA, 1995
29. Simpson DM Clinical trials of botulinum toxin in the treatment of spasticity, Muscle & Nerve 1997,6(Suppl):S169-S175.
30. O'Brien CF. Injection techniques for botulinum toxin using electromyography and electric stimulation. Muscle & Nerve 1997,6(Suppl):S176-S180